329 related articles for article (PubMed ID: 29156377)
1. Establishment of induced pluripotent stem cell line (ZZUi010-A) from an Alzheimer's disease patient carrying an APP gene mutation.
Wang Z; Zhang P; Wang Y; Shi C; Jing N; Sun H; Yang J; Liu Y; Wen X; Zhang J; Zhang S; Xu Y
Stem Cell Res; 2017 Dec; 25():213-216. PubMed ID: 29156377
[TBL] [Abstract][Full Text] [Related]
2. Generation of an integration-free iPSC line, ICCSICi006-A, derived from a male Alzheimer's disease patient carrying the PSEN1-G206D mutation.
Díaz-Guerra E; Oria-Muriel MA; Moreno-Jiménez EP; de Rojasb I; Rodríguez C; Rodríguez-Traver E; Orera M; Hernándezb I; Ruizb A; Vicario C
Stem Cell Res; 2019 Oct; 40():101574. PubMed ID: 31627126
[TBL] [Abstract][Full Text] [Related]
3. Establishment of induced pluripotent stem cell line (ZZUi009-A) from an Alzheimer's disease patient carrying a PSEN1 gene mutation.
Wang Y; Jing N; Su L; Shi C; Zhang P; Wang Z; Sun H; Yang J; Liu Y; Wen X; Zhang J; Zhang S; Xu Y
Stem Cell Res; 2018 Mar; 27():30-33. PubMed ID: 29304399
[TBL] [Abstract][Full Text] [Related]
4. A Large Panel of Isogenic APP and PSEN1 Mutant Human iPSC Neurons Reveals Shared Endosomal Abnormalities Mediated by APP β-CTFs, Not Aβ.
Kwart D; Gregg A; Scheckel C; Murphy EA; Paquet D; Duffield M; Fak J; Olsen O; Darnell RB; Tessier-Lavigne M
Neuron; 2019 Oct; 104(2):256-270.e5. PubMed ID: 31416668
[TBL] [Abstract][Full Text] [Related]
5. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
[TBL] [Abstract][Full Text] [Related]
6. Mutational analysis in early-onset familial Alzheimer's disease in Mainland China.
Jiao B; Tang B; Liu X; Xu J; Wang Y; Zhou L; Zhang F; Yan X; Zhou Y; Shen L
Neurobiol Aging; 2014 Aug; 35(8):1957.e1-6. PubMed ID: 24650794
[TBL] [Abstract][Full Text] [Related]
7. APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases.
Lanoiselée HM; Nicolas G; Wallon D; Rovelet-Lecrux A; Lacour M; Rousseau S; Richard AC; Pasquier F; Rollin-Sillaire A; Martinaud O; Quillard-Muraine M; de la Sayette V; Boutoleau-Bretonniere C; Etcharry-Bouyx F; Chauviré V; Sarazin M; le Ber I; Epelbaum S; Jonveaux T; Rouaud O; Ceccaldi M; Félician O; Godefroy O; Formaglio M; Croisile B; Auriacombe S; Chamard L; Vincent JL; Sauvée M; Marelli-Tosi C; Gabelle A; Ozsancak C; Pariente J; Paquet C; Hannequin D; Campion D;
PLoS Med; 2017 Mar; 14(3):e1002270. PubMed ID: 28350801
[TBL] [Abstract][Full Text] [Related]
8. Human fibroblast and stem cell resource from the Dominantly Inherited Alzheimer Network.
Karch CM; Hernández D; Wang JC; Marsh J; Hewitt AW; Hsu S; Norton J; Levitch D; Donahue T; Sigurdson W; Ghetti B; Farlow M; Chhatwal J; Berman S; Cruchaga C; Morris JC; Bateman RJ; ; Pébay A; Goate AM
Alzheimers Res Ther; 2018 Jul; 10(1):69. PubMed ID: 30045758
[TBL] [Abstract][Full Text] [Related]
9.
Giau VV; Bagyinszky E; Youn YC; An SSA; Kim S
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31557888
[TBL] [Abstract][Full Text] [Related]
10. Mutation profile of APP, PSEN1, and PSEN2 in Chinese familial Alzheimer's disease.
Gao Y; Ren RJ; Zhong ZL; Dammer E; Zhao QH; Shan S; Zhou Z; Li X; Zhang YQ; Cui HL; Hu YB; Chen SD; Chen JJ; Guo QH; Wang G
Neurobiol Aging; 2019 May; 77():154-157. PubMed ID: 30822634
[TBL] [Abstract][Full Text] [Related]
11. Generation of induced pluripotent stem cells (iPSCs) IRMBi002-A from an Alzheimer's disease patient carrying a D694N mutation in the APP gene.
Auboyer L; Monzo C; Wallon D; Rovelet-Lecrux A; Gabelle A; Gazagne I; Cacheux V; Lehmann S; Crozet C
Stem Cell Res; 2019 May; 37():101438. PubMed ID: 31004935
[TBL] [Abstract][Full Text] [Related]
12. Generation of a human induced pluripotent stem cell (iPSC) line from skin fibroblasts of a patient carrying an E363Q mutation in PSEN1 gene.
Zhu W; Zhou Y; Wang Q; Li J; Chu S; Jin W; Mao C; Dong L; Gao J; Xu Q
Stem Cell Res; 2022 May; 61():102769. PubMed ID: 35421846
[TBL] [Abstract][Full Text] [Related]
13. Intracellular Calcium Dysregulation by the Alzheimer's Disease-Linked Protein Presenilin 2.
Galla L; Redolfi N; Pozzan T; Pizzo P; Greotti E
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31991578
[TBL] [Abstract][Full Text] [Related]
14. Generation of a gene-corrected isogenic control cell line from an Alzheimer's disease patient iPSC line carrying a A79V mutation in PSEN1.
Pires C; Schmid B; Petræus C; Poon A; Nimsanor N; Nielsen TT; Waldemar G; Hjermind LE; Nielsen JE; Hyttel P; Freude KK
Stem Cell Res; 2016 Sep; 17(2):285-288. PubMed ID: 27879212
[TBL] [Abstract][Full Text] [Related]
15. Genetic screening in early-onset Alzheimer's disease identified three novel presenilin mutations.
Wong TH; Seelaar H; Melhem S; Rozemuller AJM; van Swieten JC
Neurobiol Aging; 2020 Feb; 86():201.e9-201.e14. PubMed ID: 30797548
[TBL] [Abstract][Full Text] [Related]
16. Familial Alzheimer's disease mutations in presenilin 1 do not alter levels of the secreted amyloid-beta protein precursor generated by beta-secretase cleavage.
Zhang C; Browne A; Kim DY; Tanzi RE
Curr Alzheimer Res; 2010 Feb; 7(1):21-6. PubMed ID: 20205669
[TBL] [Abstract][Full Text] [Related]
17. Generation of a human induced pluripotent stem cell line from a patient with a rare A673T variant in amyloid precursor protein gene that reduces the risk for Alzheimer's disease.
Lehtonen Š; Höytyläinen I; Voutilainen J; Sonninen TM; Kuusisto J; Laakso M; Hämäläinen RH; Oksanen M; Koistinaho J
Stem Cell Res; 2018 Jul; 30():96-99. PubMed ID: 29807259
[TBL] [Abstract][Full Text] [Related]
18. Presence of a mutation in PSEN1 or PSEN2 gene is associated with an impaired brain endothelial cell phenotype in vitro.
Raut S; Patel R; Al-Ahmad AJ
Fluids Barriers CNS; 2021 Jan; 18(1):3. PubMed ID: 33413468
[TBL] [Abstract][Full Text] [Related]
19. Gene Expression of Quaking in Sporadic Alzheimer's Disease Patients is Both Upregulated and Related to Expression Levels of Genes Involved in Amyloid Plaque and Neurofibrillary Tangle Formation.
Farnsworth B; Peuckert C; Zimmermann B; Jazin E; Kettunen P; Emilsson LS
J Alzheimers Dis; 2016 May; 53(1):209-19. PubMed ID: 27163826
[TBL] [Abstract][Full Text] [Related]
20. Pathological manifestation of the induced pluripotent stem cell-derived cortical neurons from an early-onset Alzheimer's disease patient carrying a presenilin-1 mutation (S170F).
Li L; Kim HJ; Roh JH; Kim M; Koh W; Kim Y; Heo H; Chung J; Nakanishi M; Yoon T; Hong CP; Seo SW; Na DL; Song J
Cell Prolif; 2020 Apr; 53(4):e12798. PubMed ID: 32216003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
